Meanwhile, the company has said it has delisted the drugs on its portal and is assisting the FDA in the investigation.
"...Upon receiving the notice, we have delisted the products and provided all information to the FDA team. We shared the details of our fulfillment center as required by the FDA team. Upon their visit to the fulfillment center, they have not found any such product. We are assisting the FDA team in this investigation," a Snapdeal spokesperson said.
Kamble added, "We received information that various drugs, including prescription drugs, are being sold online through Snapdeal.Com after which our team raided the premises of a related company."
As per the law, only a licensed retailer can sell drugs, and that too on the basis of prescription of doctor, he said, adding such type of online sale of drugs is not allowed such kind of self medication may be harmful to patients.
"In the same manner, I have also ordered FDA officials to visit the offices of other online retailers to find out whether such activities are being undertaken by them," he said.
The FDA had received specific information of actual receipt of a cough syrup and certain tablets, both prescription drugs, Kamble added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
